Combining Enzalutamide with Radium-223 Significantly Improves rPFS as First-Line Therapy for Patients with mCRPC By Ogkologos - August 27, 2025 550 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PEACE-3 study Source RELATED ARTICLESMORE FROM AUTHOR Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP NCI and CRUK Take on Cancer’s Toughest Problems Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma MOST POPULAR Can Getting a “Base Tan” Protect You From Sunburn and Skin... March 30, 2023 Sotorasib Shows Promising Activity and Acceptable Safety in Patients with Previously... January 10, 2023 DeFi Trial: Smart Design and Impressive Results For the Benefit of... September 10, 2022 How Adolescent and Young Adult Cancer Survivors Can Cope With the... November 17, 2022 Load more HOT NEWS Immunotherapy Prolongs Survival in Recurrent, Persistent or Metastatic Cervical Cancer [ESMO... FDA Approves Niraparib and Abiraterone Acetate Plus Prednisone for BRCA2-mutated Metastatic Castration-Sensitive Prostate Cancer Metastatic Breast Cancer: ESMO Clinical Practice Guideline Reflections from our chief clinician: The essential role of our research...
